Introduction
Peritoneal metastasis is the most frequent cause of death in patients with advanced gastric cancer [1] [2] [3] . In patients with serosal invasion, about half of the patients develop peritoneal recurrence and die of this disease during the first 2 years of follow-up, even if curative resection is performed [4] . It has been reported that the 5-year survival rate of patients with positive lavage cytology is only 2% [5] . Although the prognosis of patients with macroscopic dissemination of gastric carcinoma into the peritoneal cavity has proven to be disappointing [6] , adjuvant intraperitoneal therapeutic regimens with curative intent might be promising in patients with intraperitoneal free cancer cells without macroscopic peritoneal carcinomatosis. This is because the presence of intraperitoneal free cancer cells without macroscopic dissemination could possibly mean a condition wherein the implantation of cancer cells on the intraperitoneal wall has not yet occurred. If this supposition is true, the number of intraperitoneal free cancer cells could be reduced to almost zero using the method of so-called "limited dilution". If 1 liter of saline lavage reduces the number of peritoneal free cancer cells to at least one-tenth, ten such washings should lead to a logarithmic reduction of cancer cells of approximately 1:10 10 . However, because the peritoneal cavity is not a simple container, this procedure might not work as well as could be expected. If this were the case, intraperitoneal chemotherapy could be effective for eradicating the remaining cancer cells. In addition, if there were only a few cancer cells, these cells cells might find it hard to survive and form macroscopic dissemination, because the chance of implantation would be markedly reduced by the small number of viable cancer cells [7] .
Therefore, we attempted extensive lavage after curative resection prior to intraperitoneal chemotherapy for gastric cancer patients with peritoneal free cancer cells, and evaluated the clinical effects.
Abstract
The effects of extensive intraoperative peritoneal lavage (EIPL) for gastric cancer patients with peritoneal free cancer cells were investigated. This study was based on 22 consecutive patients with peritoneal free cancer cells, among 663 patients who underwent curative surgical treatment for advanced gastric cancer. The 22 patients were followed up for 2 years or until death. These patients were divided into three groups: group 1, patients with no additional intraoperative therapy (from 1989 to 1992; n ‫؍‬ 8); group 2, patients with intraoperative intraperitoneal chemotherapy alone (from 1992 to 1995; n ‫؍‬ 7); and group 3, patients with EIPL followed by intraoperative intraperitoneal chemotherapy (from 1996 to 1999; n ‫؍‬ 7). Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis showed that viable cancer cells were not detected after the eighth EIPL in a gastric cancer patient with numerous intraperitoneal free cancer cells. In group 3, 4 of the 7 patients survived for more than 2 years, including 3 with cancer-free status, whereas no patient survived cancer-free in groups 1 and 2. The peritoneal recurrence rates and cancerspecific 2-year survival rates in groups 1, 2, and 3 were 100%, 85.7% and 42.9%; and 0%, 14.3%, and 57.1%, respectively. The 2-year survival rate of group 3 was significantly higher than that of group 1 (P ‫؍‬ 0.017) and that of group 2 (P ‫؍‬ 0.025). In a subset analysis, patients with peritoneal free gastric cancer cells but no macroscopic dissemination showed a statistically significant improvement in survival those treated with EIPL compared with those not treated with EIPL.
Patients
Between 1989 and 1999, 663 patients with advanced gastric carcinoma underwent potentially curative operation with extended lymph node dissection at the Department of Surgery, Yatsushiro Health Insurance General Hospital, and the Second Department of Surgery, Kumamoto University Medical School, and a total of 22 consecutive patients who had peritoneal free cancer cells by cytological examination but had no macroscopic dissemination was selected. These patients were divided into three groups: group 1, patients without extensive intraoperative peritoneal lavage (EIPL) or chemotherapy (from 1989 to 1992; n ϭ 8); group 2, patients with only intraoperative intraperitoneal chemotherapy (from 1993 to 1995; n ϭ 7); and group 3, patients with both the EIPL and chemotherapy (from 1996 to 1999; n ϭ 7). Pathologic diagnosis and classifications were based on the Japanese classification of gastric carcinoma outlined by the Japanese Research Society for Gastric Cancer [8] . All patients received adjuvant chemotherapy (oral administration of 5-fluorouracil derivatives) after the surgical treatment, and all gave their informed consent.
Cytological detection of free cancer cells in the peritoneal cavity
The surgical tumor stage was sufficiently examined after laparotomy. When no macroscopic dissemination was detected, 100 ml of physiologic saline was introduced into the abdominal cavity and manually dispersed. The introduced fluid was collected from several regions of the abdominal cavity, such as the left and right subphrenic areas and the pouch of Douglas. Immediately after the collection, 1 ml of heparin was added to the fluid. Half of the fluid was centrifuged at 1000 g for 10 min, and the nucleated cell layer was smeared onto a glass slide and stained according to the Papanicolaou, Giemsa, and periodic acid Schiff (PAS) methods. The remaining fluid was used for reverse transcriptasepolymerase chain reaction (RT-PCR) analysis.
Extensive intraoperative peritoneal lavage (EIPL) and chemotherapy
Immediately after the cytological report showing positivity for peritoneal malignant cells, the contents of the peritoneal cavity were diluted with 1 liter of physiologic saline and completely aspirated, this procedure being done three times. After the potentially curative operation was performed, the peritoneal cavity was extensively washed, using 7 liters of physiologic saline (1 liter, seven times) followed by intraperitoneal chemotherapy, and 200 ml of each sample was collected for consecutive cytological and RT-PCR analysis. After the extensive washing and aspiration, 100 mg of cisplatin (CDDP) was administered into the peritoneal cavity. Peritoneal lavage for groups 1 and 2 was done with 3 liters (1 liter, three times) before closure of the abdominal wall or chemotherapy, respectively.
RT-PCR
The lavage samples (approximately 200 ml) were centrifuged at 1000 g for 10 min at 4°C to collect intact cells, and resuspended in 1 ml of TRIzol Reagent (Invitrogen, Carlsbad, CA, USA). Total RNAs were isolated according to the guanidinium-thiocyanate-phenol-chloroform method [9] . The cDNA was synthesized from approximately 1 µg of the total RNA. The presence of carcinoembryonic antigen (CEA) cDNA in the reverse transcription products was detected by PCR amplification in separate reactions, using oligonucleotide primers of this gene. PCR was carried out as described by Gerhard et al. [10] . To ensure that the RNA was of sufficient purity for RT-PCR, a PCR assay with primers specific for a housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA was carried out in each sample, except that only 35 cycles were performed, under the following cycling conditions: 1 min at 94°C, 2 min at 56°C, and 2 min at 72°C. The primer sequences for GAPDH were: 5Ј-ATGGA TGATGATATCGCCGCG-3Ј and 5Ј-CTAGAAGCA TTTGCGGTGGACGATGGAGG GGCC-3Ј. Firststrand cDNA was synthesized using SuperScript II reverse transcriptase (Gibco BRL, Gaithersburg, MD, USA) and random hexanucleotide primers (Pharmacia Biotech, Uppsala, Sweden) according to the manufacturer's instructions. CEA-specific oligonucleotide primers synthesized for the nested RT-PCR analyses were those reported by Gerhard et al. [10] . The first PCR amplification was performed using primers CEA-A and CEA-B, followed by a second PCR amplification using primers CEA-C and CEA-B. The CEA primer sequences were: CEA-A, 5Ј-TCTGGAAC TTCTCCTGGTCTCTCAGCTGG-3Ј; CEA-B, 5Ј-TGTAGCTGTTGCAAATGCTTTAAGG AAGAAGC-3Ј; and CEA-C, 5Ј-GGGCCACTGTCG GCATCA TGATTGG-3Ј. For the first PCR amplification, 1 µl of the cDNA synthesis mix was used in a final volume of 25 µl. The amplification conditions included denaturation at 95°C for 30 s, annealing at 63°C for 1 min, and extension at 72°C for 1 min, for 30 cycles, followed by a final extension step at 72°C for 5 min. The second nested PCR amplification was performed in the same way, using 2 µl of the first PCR reaction mix and the primers CEA-C and CEA-B. The amplification con-ditions were the same as those for the first PCR, except for the annealing, which was done at 60°C. The external (first) CEA RT-PCR resulted in a 160-bp fragment, and the internal (second) PCR amplification yielded a 131-bp product.
RT-PCR analysis of fluid obtained from the EIPL
We were very interested in determining when the malignant cells disappeared from the lavage fluid, at the level of molecular biological detection, as a result of the frequent and extensive washing, aspiration, and dilution. Therefore, the RT-PCR method was applied to each batch of lavage fluid in one patient in group 3 who had numerous free cancer cells in the peritoneal cavity at the time of laparotomy, according to the result of cytological examination (Fig. 1) . Cytological examination revealed that cancer cells were not detected in the washing fluid after the fourth lavage, except for a detection in the washing fluid after the sixth lavage, in which only one cluster of cancer cells was detected. In the RT-PCR analysis using specific primers for CEA, no RT-PCR product was detected in the washing fluid after the eighth lavage. On the other hand, the RT-PCR product of CEA was observed in all the batches of lavage fluid of a patient with visible peritoneal dissemination. Based on these RT-PCR analyses, it was assumed that extensive washing using 10 liters of physiologic saline (1 liter, ten times) might flush out the free cancer cells from the peritoneal cavity according to the law of "limited dilution".
Impact of EIPL on recurrence pattern and 2-year survival rate
All patients who underwent potentially curative resection without EIPL or chemotherapy (group 1) had peritoneal recurrence (100%) and died within 2 years. All but one of the patients who underwent curative resection with intraperitoneal chemotherapy alone (group 2) also died within 2 years. However, the recurrence pattern in the group 2 patients included a patient who died of lung metastasis. One patient survived for more than 2 years with peritoneal recurrence. The overall peritoneal recurrence rate during 2-year follow-up was 85.7% (six of seven) in group 2. On the other hand, in the patients who underwent curative resection with both the EIPL and chemotherapy (group 3), only three of the seven patients (42.9%) had peritoneal recurrence. The remaining four patients have not had peritoneal recurrence during 2-year follow-up and are still alive, although one of the four patients has skin recurrence. The 2-year survival rates of groups 1, 2, and 3 were 0, 14.3% and 57.1%, respectively. The Kaplan-Meier survival curves for the three studied groups are shown in Fig. 2 . The cancer-specific 2-year survival curve of group 3 differed significantly from those of group 1 and group 2 (P ϭ 0.017 and P ϭ 0.025, respectively). There was no significant difference between group 1 and group 2.
Discussion
Attention has been directed toward the detection of peritoneal free cancer cells to predict the prognosis of patients with advanced gastric carcinoma without overt peritoneal carcinomatosis [11] . However, the results of such studies have not been fully reflected in the treatment. On the other hand, some prospective randomized trials of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer have shown that patients with stage III gastric cancer had a statistically significant improvement in survival when treated with perioperative chemotherapy [12] . Intraperitoneal chemotherapy has been designed to eradicate residual microscopic disease present in the peritoneal cavity after cancer resection. These studies would suggest that intraperitoneal chemotherapy could be effective to eradicate a few residual carcinoma cells. Because the small water-soluble molecules of commonly used anticancer drugs, such as CDDP or mitomycin C, are rapidly absorbed through capillary walls in the subperitoneum, an effective concentration of the drugs is not maintained for long in the peritoneal cavity, resulting in such treatment playing an insufficient role to eradicate a large number of cancer cells [13] . The present study clearly showed that the peritoneal recurrence rate was substantially reduced when EIPL and chemotherapy were performed (group 3). Recently, it has been reported that the use of a peritoneal immunological method, with a combination of selected monoclonal antibodies, allowed the identification of cytologically false-negative cases in gastric cancer [11] . In these studies, Kaplan-Meier curves showed a statistically significant decrease of peritoneal recurrence in patients with peritoneal free cancer cells detected by immunocytochemical methods compared with the findings in patients with peritoneal free cancer cells detected morphologically. These data suggest that immunocytochemical detection is more sensitive than morphological cytology, and that gastric cancer patients with a smaller number of peritoneal free cancer cells than can be identified morphologically tend not to develop peritoneal recurrence. Sensitive methods, such as the immunological staining of cancer cells or RT-PCR examination for the detection of malignant cells, may be useful to select patients for the kind of treatment used in the present study (i.e., EIPL). However, because these methods are not generally available at the time of operation, cytological examination is commonly used to detect the free cancer cells in the peritoneal cavity. Therefore, at the present time, EIPL should be employed for all gastric cancer patients with serosal invasion, including those with cytologically detected free cancer cells, because intraperitoneal free cancer cells have been detected by an immunological method in many patients with serosal invasion [11] .
Free cancer cells in the peritoneal cavity are certainly important for the development of peritoneal recurrence in patients with gastric cancer. Frequent washing, and complete aspiration and dilution may not be an interesting procedure at the end of an operation, but it is quite a powerful method for reducing the number of cells to, potentially, zero, just like the so-called "limited dilution". Furthermore, because EIPL followed by intraperitoneal chemotherapy is simple, not so timeconsuming, and inexpensive, it can be performed anywhere and at any time. The use of EIPL may be indicated not only for patients with peritoneal gastric free cancer cells but also for those with gastric cancer invaded to the serosa. Thus, this protocol needs to be examined in larger scale trials and subjected to randomized controlled trials in the near future. 
